Literature DB >> 19033655

Cardiac troponin T mutations promote life-threatening arrhythmias.

Céline Fiset1, Wayne R Giles.   

Abstract

Mutations in contractile proteins in heart muscle can cause anatomical changes that result in cardiac arrhythmias and sudden cardiac death. However, a conundrum has existed because mutations in one such contractile protein, a so-called Ca2+ sensor troponin T (TnT), can promote ventricular rhythm disturbances even in the absence of hypertrophy or fibrosis. Thus, these mutations must enhance abnormal electrophysiological events via alternative means. In this issue of the JCI, Baudenbacher et al. report a novel mechanism to explain this puzzle (see the related article beginning on page 3893). They show that a selected TnT mutation in the adult mouse heart can markedly increase the sensitivity of cardiac muscle myofilaments to Ca2+ and enhance the susceptibility to arrhythmia, even in the absence of anatomical deformities. As these same mutations can cause some forms of arrhythmias in humans, these findings are of both basic and translational significance.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 19033655      PMCID: PMC2582939          DOI: 10.1172/JCI37787

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  26 in total

1.  Arrhythmogenesis and contractile dysfunction in heart failure: Roles of sodium-calcium exchange, inward rectifier potassium current, and residual beta-adrenergic responsiveness.

Authors:  S M Pogwizd; K Schlotthauer; L Li; W Yuan; D M Bers
Journal:  Circ Res       Date:  2001-06-08       Impact factor: 17.367

2.  Role of sarcolemmal K(ATP) channels in cardioprotection against ischemia/reperfusion injury in mice.

Authors:  Masashi Suzuki; Norihito Sasaki; Takashi Miki; Naoya Sakamoto; Yuki Ohmoto-Sekine; Masaji Tamagawa; Susumu Seino; Eduardo Marbán; Haruaki Nakaya
Journal:  J Clin Invest       Date:  2002-02       Impact factor: 14.808

Review 3.  Hypertrophic cardiomyopathy:a paradigm for myocardial energy depletion.

Authors:  Houman Ashrafian; Charles Redwood; Edward Blair; Hugh Watkins
Journal:  Trends Genet       Date:  2003-05       Impact factor: 11.639

4.  MCC-134, a single pharmacophore, opens surface ATP-sensitive potassium channels, blocks mitochondrial ATP-sensitive potassium channels, and suppresses preconditioning.

Authors:  Norihito Sasaki; Mitsushige Murata; Yiru Guo; Su-Hyun Jo; Andreas Ohler; Masaharu Akao; Brian O'Rourke; Rui-Ping Xiao; Roberto Bolli; Eduardo Marbán
Journal:  Circulation       Date:  2003-03-04       Impact factor: 29.690

5.  Familial hypertrophic cardiomyopathy-linked mutant troponin T causes stress-induced ventricular tachycardia and Ca2+-dependent action potential remodeling.

Authors:  Björn C Knollmann; Paulus Kirchhof; Syevda G Sirenko; Hubertus Degen; Anne E Greene; Tilmann Schober; Jessica C Mackow; Larissa Fabritz; James D Potter; Martin Morad
Journal:  Circ Res       Date:  2003-02-06       Impact factor: 17.367

6.  Computer model of action potential of mouse ventricular myocytes.

Authors:  Vladimir E Bondarenko; Gyula P Szigeti; Glenna C L Bett; Song-Jung Kim; Randall L Rasmusson
Journal:  Am J Physiol Heart Circ Physiol       Date:  2004-05-13       Impact factor: 4.733

7.  Familial hypertrophic cardiomyopathy mutations from different functional regions of troponin T result in different effects on the pH and Ca2+ sensitivity of cardiac muscle contraction.

Authors:  Keita Harada; James D Potter
Journal:  J Biol Chem       Date:  2004-01-12       Impact factor: 5.157

8.  Changes in extracellular K+ concentration modulate contractility of rat and rabbit cardiac myocytes via the inward rectifier K+ current IK1.

Authors:  Ron Bouchard; Robert B Clark; Alexander E Juhasz; Wayne R Giles
Journal:  J Physiol       Date:  2004-02-27       Impact factor: 5.182

9.  Myofilament Ca2+ sensitization causes susceptibility to cardiac arrhythmia in mice.

Authors:  Franz Baudenbacher; Tilmann Schober; Jose Renato Pinto; Veniamin Y Sidorov; Fredrick Hilliard; R John Solaro; James D Potter; Björn C Knollmann
Journal:  J Clin Invest       Date:  2008-11-20       Impact factor: 14.808

10.  Hypertrophic cardiomyopathy due to sarcomeric gene mutations is characterized by impaired energy metabolism irrespective of the degree of hypertrophy.

Authors:  Jenifer G Crilley; Ernest A Boehm; Edward Blair; Bheeshma Rajagopalan; Andrew M Blamire; Peter Styles; William J McKenna; Ingegerd Ostman-Smith; Kieran Clarke; Hugh Watkins
Journal:  J Am Coll Cardiol       Date:  2003-05-21       Impact factor: 24.094

View more
  8 in total

1.  Familial dilated cardiomyopathy. Clinical and genetic characteristics.

Authors:  A Serio; N Narula; T Kodama; V Favalli; E Arbustini
Journal:  Herz       Date:  2012-12       Impact factor: 1.443

Review 2.  A primer on arrhythmias in patients with hypertrophic cardiomyopathy.

Authors:  Katy E Bockstall; Mark S Link
Journal:  Curr Cardiol Rep       Date:  2012-10       Impact factor: 2.931

3.  Pathogenic peptide deviations support a model of adaptive evolution of chordate cardiac performance by troponin mutations.

Authors:  Nathan J Palpant; Evelyne M Houang; Wayne Delport; Kenneth E M Hastings; Alexey V Onufriev; Yuk Y Sham; Joseph M Metzger
Journal:  Physiol Genomics       Date:  2010-04-27       Impact factor: 3.107

Review 4.  Definition and treatment of arrhythmogenic cardiomyopathy: an updated expert panel report.

Authors:  Perry M Elliott; Aris Anastasakis; Angeliki Asimaki; Cristina Basso; Barbara Bauce; Matthew A Brooke; Hugh Calkins; Domenico Corrado; Firat Duru; Kathleen J Green; Daniel P Judge; David Kelsell; Pier D Lambiase; William J McKenna; Kalliopi Pilichou; Alexandros Protonotarios; Jeffrey E Saffitz; Petros Syrris; Hari Tandri; Anneline Te Riele; Gaetano Thiene; Adalena Tsatsopoulou; J Peter van Tintelen
Journal:  Eur J Heart Fail       Date:  2019-06-18       Impact factor: 15.534

Review 5.  Genetic mutations and mechanisms in dilated cardiomyopathy.

Authors:  Elizabeth M McNally; Jessica R Golbus; Megan J Puckelwartz
Journal:  J Clin Invest       Date:  2013-01-02       Impact factor: 14.808

Review 6.  Animal models of arrhythmogenic cardiomyopathy.

Authors:  Mark D McCauley; Xander H T Wehrens
Journal:  Dis Model Mech       Date:  2009 Nov-Dec       Impact factor: 5.758

Review 7.  Personalizing Risk Stratification for Sudden Death in Dilated Cardiomyopathy: The Past, Present, and Future.

Authors:  Brian P Halliday; John G F Cleland; Jeffrey J Goldberger; Sanjay K Prasad
Journal:  Circulation       Date:  2017-07-11       Impact factor: 29.690

8.  Rationale, objectives, and design of the EUTrigTreat clinical study: a prospective observational study for arrhythmia risk stratification and assessment of interrelationships among repolarization markers and genotype.

Authors:  Joachim Seegers; Marc A Vos; Panagiota Flevari; Rik Willems; Christian Sohns; Dirk Vollmann; Lars Lüthje; Dimitrios T Kremastinos; Vincent Floré; Mathias Meine; Anton Tuinenburg; Rachel C Myles; Dirk Simon; Jürgen Brockmöller; Tim Friede; Gerd Hasenfuß; Stephan E Lehnart; Markus Zabel
Journal:  Europace       Date:  2011-11-23       Impact factor: 5.214

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.